In contrast, S‐phase‐specific activation of PKCα induced senescence in non‐small cell lung cancer (NSCLC) cells, and similarly, inhibition of PKCα promoted breast cancer immune escape by maintaining the stability of programmed cell death 1 ligand 1 (PD‐L1) [39, 40]. This evidence concerns the gene CD274 and breast carcinoma.